1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6937F7D39A4D6EF5B85256E4500756D26
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/managing-cross-functional-pharmaceutical-launch-teams?opendocument
18
19opendocument
203.237.15.145
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Product Launch » Product Launch Excellence

Managing Cross-Functional Pharmaceutical Launch Teams

DB Image

ID: 4568

Features:

Metrics, Graphics, Summary Matrix, Detailed Process Map

Pages/Slides: 17

Published: Pre-2019

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Leading pharmaceutical companies have learned that team management is a complex process. Launch teams must be able to utilize resources and expertise within the company, sustain a coherent approach through transitions, and prepare products for a successful launch.

This 17-page document details how creating an effective launch team is imperative to ensuring the success of a new product’s launch. Cross-functional launch teams can use this information to execute a drug development plan that can shape a compound into a commercially successful product for the company.

Key topics covered in this document include:
-Incentives and Support
-Launch Team Structure
-Ongoing Marketing Activities

Select best practices include:
1. Create a cross-functional launch team to ensure a seamless product rollout.
- Various benchmark partners employ cross-functional teams to effectively launch new products. Most have a unique team comprised of eight to nine members within each launch country.
2. Align incentives to encourage cross-functional cooperation.
- One benchmark partner is beginning to see a more unified approach to development from the clinical and commercial sides by aligning clinical and commercial’s compensation, bonuses and evaluation.
3. Use a variety of financial and strategic factors to determine product ranking within the company portfolio.
- One benchmark partner has an extensive annual portfolio planning process that involves ranking all drugs in early stage discovery to Phase III development, by order of importance and allocation level.

This research originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device


Companies Profiled:
Merck; Sanofi-aventis; Eli Lilly; GlaxoSmithKline; Novartis; Pfizer; Johnson & Johnson; Bristol-Myers Squibb; AstraZeneca; Roche; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH